The aim is to develop a targeted MXene nanoplatform that enhances the effectiveness of chemotherapy and immunotherapy in treating bladder cancer.
Developed a tumor cell membrane-engineered MXene nanoplatform.
Conducted in vitro assessments of therapeutic efficacy.
Utilized a combination of chemo- and photothermal therapies.
Significant improvement in tumor cell targeting and drug delivery efficacy.
Enhanced immune responses observed in treated models.
Potential for reduced recurrence rates noted.
Abstract
Bladder cancer is a major clinical challenge due to high recurrence and limited efficacy of conventional therapies, creating an urgent demand for localized and targeted strategies. In this study, we...